Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab-Reference-Cited by-同舟云学术

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab

Published:2023-05 Issue:4 Volume:61 Page:320-326
ISSN:0266-4356
Container-title:British Journal of Oral and Maxillofacial Surgery
language:en
Short-container-title:British Journal of Oral and Maxillofacial Surgery

Author:

Tachinami Hidetake,Tomihara Kei,Yamada Shin-ichi,Ikeda Atsushi,Imaue Shuichi,Hirai Hideaki,Nakai Hiromi,Sonoda Tomoko,Kurohara Kazuto,Yoshioka Yukio,Hasegawa Takumi,Naruse Tomofumi,Niiyama Takashi,Shimane Tetsu,Ueda Michihiro,Yanamoto Souichi,Akashi Masaya,Umeda Masahiro,Kurita Hiroshi,Miyazaki Akihiro,Arai Naoya,Hayashi Ryuji,Noguchi Makoto

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Otorhinolaryngology,Oral Surgery,Surgery

Reference31 articles.

1. Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma;Moy;Eur J Cancer,2017

2. Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): a systematic literature review;Lala;Oral Oncol,2018

3. Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy?;Spector;Laryngoscope,2012

4. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck;Argiris;Cancer,2004

5. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression;Ferris;Oral Oncol,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory markers as prognostic markers in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Frontiers in Oncology;2024-07-26

2. C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCC;Cancers;2024-06-30

3. Rapamycin Induces Phenotypic Alterations in Oral Cancer Cells That May Facilitate Antitumor T Cell Responses;Biomedicines;2024-05-13

4. The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma;Cancers;2024-03-04

5. The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patients;Medicine;2023-08-04